Explore Investments LLC/DE - 25 Jul 2025 SCHEDULE 13G Report for Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL)

Filing Manager
Explore Investments LLC/DE
Reporting Manager
Explore Investments LLC
Security
Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share
Symbol
LYEL
Shares outstanding
19,277,111 shares
Disclosed Ownership
1,040,964 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
19 Aug 2025, 16:10:24 UTC
Date of event
25 Jul 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Explore Investments LLC/DE disclosed 5.4% ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL) on 25 Jul 2025."

Quick Takeaways

  • Explore Investments LLC/DE filed SCHEDULE 13G for Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL).
  • Disclosed ownership: 5.4%.
  • Date of event: 25 Jul 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 19 Aug 2025, 16:10.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Explore Investments LLC 5.4% 1,040,964 0 1,040,964 /s/ Paul Dauber Paul Dauber/its Manager
Jeffrey P. Bezos 5.4% 1,040,964 0 1,040,964 /s/ Jeffrey P. Bezos Jeffrey P. Bezos/an Individual

Sponsored